Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Health professionals often prefer it because it stays in your body longer than other types, which is a huge plus for anyone with a busy schedule
The human clinical trial data is thinner
HGF/c-Met signaling is a well-established oncogenic pathway: c-Met is amplified or overexpressed in multiple cancers (gastric, lung, renal, hepatocellular) HGF/c-Met activation promotes tumor cell proliferation, survival, invasion, and metastasis c-Met inhibitors are FDA-approved cancer drugs (cabozantinib, crizotinib, capmatinib) A compound that potentiates HGF/c-Met signaling raises theoretical concerns about promoting tumor growth or transformation with chronic use
Results vary depending on the study design, model, and conditions used
Improved vascular health: BPC-157s angiogenic properties may enhance nutrient delivery and circulation throughout the body, supporting overall wellness
US$ 20.90
US$ 20.30
US$ 20.75
US$ 23.06
US$ 26.63
US$ 20.70
US$ 23.67
US$ 21.90